1. Home
  2. VOR vs CII Comparison

VOR vs CII Comparison

Compare VOR & CII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

N/A

Current Price

$19.18

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo Blackrock Capital and Income Fund Inc.

CII

Blackrock Capital and Income Fund Inc.

N/A

Current Price

$21.09

Market Cap

979.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VOR
CII
Founded
2015
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
979.0M
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
VOR
CII
Price
$19.18
$21.09
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
★ $39.00
N/A
AVG Volume (30 Days)
★ 636.5K
74.7K
Earning Date
10-30-2026
01-01-0001
Dividend Yield
N/A
★ 6.17%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.21
$20.43
52 Week High
$26.00
$26.17

Technical Indicators

Market Signals
Indicator
VOR
CII
Relative Strength Index (RSI) 48.50 26.21
Support Level $17.62 $21.16
Resistance Level $20.11 $24.93
Average True Range (ATR) 1.29 0.50
MACD -0.09 -0.18
Stochastic Oscillator 44.48 2.84

Price Performance

Historical Comparison
VOR
CII

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

About CII Blackrock Capital and Income Fund Inc.

Blackrock Enhanced Cap&Inc Fund, Inc is a closed-end management investment company. Its investment objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing in a portfolio of equity securities of U.S. and foreign issuers. It may invest directly in such securities or synthetically through the use of derivatives. It also seeks to achieve its investment objective by employing a writing (selling) call and put options.

Share on Social Networks: